Rani Therapeutics Holdings Inc - Ordinary Shares Class A

-0.02 (-0.36%)
5:47:53 PM EDT: $5.82 +0.27 (+4.87%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)136.70M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.11 Million
Adjusted EPS-$0.41
See more estimates
10-Day MA$5.73
50-Day MA$6.77
200-Day MA$9.14
See more pivots

Rani Therapeutics Holdings Inc - Ordinary Shares Class A Stock, NASDAQ:RANI

2051 Ringwood Avenue, San Jose, California 95131
United States of America
Phone: +1.408.457.3700
Number of Employees: 114


Rani Therapeutics Holdings, Inc. operates as a clinical stage bio-therapeutics company providing technologies to enable the development of orally administered biologics. It offers RaniPill capsule, an orally ingestible pill for the administration of a broad range of biologics. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.